Scientific Co-Founders

alexander-rudensky-ph-d

Alexander Rudensky, Ph.D.

Scientific Co-Founder

alexander-rudensky-ph-d

Alexander Rudensky, Ph.D.

Scientific Co-Founder

Alexander Rudensky is Chairman of the Immunology Program and Director of the Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center (MSKCC), an Investigator with the Howard Hughes Medical Institute, and a Triā€Institutional Professor at Dr. Rudensky's research is focused on the differentiation of regulatory T lymphocytes, and their role in the immune responses. His laboratory demonstrated a role for the transcription factor Foxp3 as a Treg cell lineage specification factor. Dr. Rudensky's work provided important insights into the fundamental role for regulatory T cells in immunological tolerance and in a variety of processes and pathologies including autoimmunity, allergy, transplantation, immunity to infections, pregnancy, tissue repair, and cancer.

Dr. Rudensky is an elected Member of the National Academy of Sciences, and National Academy of Medicine, and a Fellow of the American Academy of Arts and Sciences

ruslan-medzhitov-ph-d

Ruslan Medzhitov, Ph.D.

Co-Founder & Chair of SAB

ruslan-medzhitov-ph-d

Ruslan Medzhitov, Ph.D.

Co-Founder & Chair of SAB

Dr. Medzhitov is best known for his work pioneering our current understanding of the innate immune system. He identified a human homologue of Drosophila Toll known as TLR4, and has since contributed to the characterization of the mammalian TLR family.

Dr. Medzhitov has received numerous awards including the prestigious Rosenstiel Award for Distinguished Work in Basic Medical Research, the Shaw Prize in Life Science and Medicine, and the Emil von Behring Award. He is a Howard Hughes Medical Institute Investigator and Sterling Professor of Immunobiology at Yale University School of Medicine. Dr. Medzhitov is a member of the National Academy of Sciences and the National Academy of Medicine.

dan-littman-m-d-ph-d

Dan Littman, M.D., Ph.D.

Scientific Co-Founder

dan-littman-m-d-ph-d

Dan Littman, M.D., Ph.D.

Scientific Co-Founder

Dr. Littman has made numerous groundbreaking discoveries in the field of virology and immunology, including identification and isolation of receptors required for HIV entry, molecular mechanisms of immune cells that mediate autoimmunity, and the role of specific members of the gut microbiota in T cell differentiation.

Dr. Littman is a Howard Hughes Medical Institute Investigator, and the Helen L. and Martin S. Kimmel Professor of Molecular Immunology and Professor of Pathology and Microbiology at New York University School of Medicine. He is a Fellow of the American Academy of Arts and Sciences and a member of the National Academy of Sciences. He was awarded the 2004 New York City Mayor's Award for Excellence in Science and Technology.

brett-finlay-ph-d

Brett Finlay, Ph.D.

Scientific Co-Founder

brett-finlay-ph-d

Brett Finlay, Ph.D.

Scientific Co-Founder

Dr. Finlay's research interests are focused on host-pathogen interactions at the molecular level. He has made several fundamental discoveries in this field, and published over 500 papers.

Dr. Finlay is recognized internationally for his work, and has been named a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences, an Officer of Canada, and been awarded the Order of British Columbia. He is the Director of the SARS Accelerated Vaccine Initiative. Dr. Finlay is a Howard Hughes Medical Institute Investigator and a Professor at the University of British Columbia.

kenya-honda-m-d-ph-d

Kenya Honda, M.D., Ph.D.

Scientific Co-Founder

kenya-honda-m-d-ph-d

Kenya Honda, M.D., Ph.D.

Scientific Co-Founder

Kenya Honda is a Professor of Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, JAPAN; and also the Team leader of Laboratory for Gut Homeostasis, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, JAPAN. He received his M.D. from Kobe University School of Medicine and his Ph.D. from Kyoto University School of Medicine in Japan. His research focuses on the immunological attributes of the gut microbiota and trying to identify functionally relevant members of the microbiota and their derived factors. He received the Gottfried Wagener Prize in 2014 and Baelz Prize in 2016. Dr. Honda is the lead inventor in multiple technologies exclusively licensed to Vedanta.

jeremiah-faith-ph-d

Jeremiah Faith, Ph.D.

Scientific Advisor

jeremiah-faith-ph-d

Jeremiah Faith, Ph.D.

Scientific Advisor

Dr. Faith is Assistant Professor of Clinical Immunology and Genetics and Genomic Sciences, at the Icahn School of Medicine at Mount Sinai Hospital in New York. His work there focuses on the manipulation of the gut microbiota, the interactions between our gut microbes and our immune system, and the development of new computational and experimental technologies to better model and assay the interactions between our gut microbes and our health.

Dr. Faith has recently authored multiple high impact publications in Science, Science Translational Medicine and PNAS studying microbe-host relationships using bacterial consortia, the stability of the human microbiota and its response to diet, and bacterial culture methods.